Lateral mucosal advancement anoplasty for anal stricture by Rakhmanine, M., Rosen, L., Khubchandani, I., Stasik, J., Riether, R. D.

Get full text

Endorectal repair of rectocele revisited by Khubchandani, I. T., Clancy III, J. P., Rosen, L., Riether, R. D., Stasik Jr, J. J.

Get full text

Comparing predictive decision rules in postoperative CEA monitoring by Denstman, Frederick, Rosen, Lester, Khubchandani, Indru T., Sheets, James A., Stasik, John J., Riether, Robert D.

Get full text

Hepatic arterial infusion chemotherapy by Kim, R S., Riether, R D., Hoover, H C.

Get full text

LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells by Höpner, S. S., Raykova, Ana, Radpour, R., Amrein, M. A., Koller, D., Baerlocher, G. M., Riether, C., Ochsenbein, A. F.

Get full text

Chemotherapy negatively impacts the tumor immune microenvironment in NSCLC: an analysis of pre- and post-treatment biopsies in the multi-center SAKK19/09 study by Amrein, M. A., Bührer, E. D., Amrein, M. L., Li, Q., Rothschild, S., Riether, C., Jaggi, R., Savic-Prince, S., Bubendorf, L., Gautschi, O., Ochsenbein, A. F.

Get full text

mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer by Liang, Shun-Qing, Bührer, Elias D., Berezowska, Sabina, Marti, Thomas M., Xu, Duo, Froment, Laurène, Yang, Haitang, Hall, Sean R. R., Vassella, Erik, Yang, Zhang, Kocher, Gregor J., Amrein, Michael A., Riether, Carsten, Ochsenbein, Adrian F., Schmid, Ralph A., Peng, Ren-Wang

Get full text

Selective CB2 receptor agonists. Part 2: Structure–activity relationship studies and optimization of proline-based compounds by Riether, Doris, Zindell, Renee, Wu, Lifen, Betageri, Raj, Jenkins, James E., Khor, Someina, Berry, Angela K., Hickey, Eugene R., Ermann, Monika, Albrecht, Claudia, Ceci, Angelo, Gemkow, Mark J., Nagaraja, Nelamangala V., Romig, Helmut, Sauer, Achim, Thomson, David S.

Get full text

MA 15.11 CCNE1, PTGS2, TGFA and WISP2 Predict Benefit from Bevacizumab and Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer (SAKK19/09) by Rothschild, S., Amrein, M., Riether, C., Gautschi, O., Schuster, N., Li, Q., Savic, S., Schneider, M., Biaggi, C., Bubendorf, L., Brutsche, M., Zippelius, A., Zander, T., Betticher, D., Früh, M., Stahel, R., Cathomas, R., Rauch, D., Pless, M., Ochsenbein, A., Jaggi, R.

Get full text

5-Aminomethylbenzimidazoles as potent ITK antagonists by RIETHER, Doris, ZINDELL, Renée, RAYMOND, Ernest L, KHINE, Hnin Hnin, O'SHEA, Kathy, WOSKA, Joseph R, JEANFAVRE, Deborah, SELLATI, Rosemarie, RALPH, Kerry L. M, AHLBERG, Jennifer, LABISSIERE, Gabriel, KASHEM, Mohammed A, KOWALSKI, Jennifer A, PULLEN, Steven S, TAKAHASHI, Hidenori, COOK, Brian N, BENTZIEN, Jörg, DE LOMBAERT, Stéphane, THOMSON, David, KUGLER, Stanley Z, SKOW, Donna, MARTIN, Leslie S

Get full text